LU
Lunai Bioworks Inc.
RENB | US
Overview
Corporate Details
- ISIN(s):
- US29350E1047
- LEI:
- Country:
- United States of America
- Address:
- CENTURY CITY MEDICAL PLAZA, 90067 SUITE 906 LOS ANGELES
- Website:
- https://www.lunaibio.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lunai Bioworks Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Lunai Bioworks Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lunai Bioworks Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Digital brain health assessment platform for CNS clinical trials and research.
United Kingdom
COG
United Kingdom
COG
Japan
4575
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Poland
CTX
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
United States of America
CRDF
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
United States of America
CDIO
Clinical-stage biotech developing oral drug simufilam for CNS disorders like TSC-related epilepsy.
United States of America
SAVA
United States of America
SAVA
Developing targeted PI3K/mTOR inhibitor therapies for breast and prostate solid tumors.
United States of America
CELC
United States of America
CELC
Develops immunotherapies for cancer, autoimmune, and infectious diseases.
United States of America
CVM
United States of America
CVM
Clinical-stage biotech developing CAR T therapies for solid and blood cancers.
Belgium
CYAD
Belgium
CYAD